SI-BONE, Inc.

SI-BONE, Inc. is a medical device company that develops procedural solutions for compromised bone, leveraging expertise in biomechanical design and anatomy-specific applications. The company offers a series of patented titanium implants and instruments used to implant them, as well as implantable bone products. Its flagship product is the iFUSE implant system, which includes triangular titanium implants with porous surfaces designed to stabilize joints and facilitate bone fusion. The portfolio also includes iFUSE 3D, iFUSE BONE, iFUSE TORQ, iFUSE BEDROCK GRANITE, and iFUSE TORQ TNT, each with unique features such as fenestrated designs, threaded structures, or capabilities for spanning the posterior pelvis. These products are used in orthopedic procedures, particularly for sacroiliac joint fusion and spinal fusion.

SI-BONE, Inc. is listed on the Nasdaq Global Market (NasdaqGM) under the ticker symbol SIBN. The company operates in the United States and its financial reporting is conducted in US Dollars (USD). As a publicly traded company on a major US exchange, its stock is available for trading by investors worldwide, and its financial statements are denominated in USD, reflecting its primary operations in the United States.

SI-BONE, Inc. operates in the Healthcare sector, specifically within the Medical Devices industry. This means the company is involved in designing, manufacturing, and marketing medical devices used for surgical procedures. Its focus is on developing implants and instruments for orthopedic applications, particularly for conditions involving compromised bone. The Medical Devices industry is highly regulated and requires significant expertise in biomechanics and materials science, which aligns with SI-BONE's core competencies in creating titanium implants with advanced surface technologies to promote bone fusion and stabilization.

SI-BONE, Inc. is headquartered in Santa Clara, California, United States. The company was incorporated in 2008 and serves markets in the United States and globally. Its products are marketed primarily through a direct sales force, as well as through third-party sales agents and resellers. The company's global reach includes international markets where its medical devices are used in orthopedic and neurosurgical procedures. The headquarters location in Silicon Valley provides access to a skilled workforce and proximity to innovation hubs, supporting its research and development efforts.

SI-BONE's main products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The iFUSE implant is a triangular titanium implant with a porous surface that stabilizes the sacroiliac joint and facilitates bone fusion. Other products include iFUSE 3D, which has a fenestrated design to self-harvest bone; iFUSE BONE, which supports and augments the patient's own bone tissue; iFUSE TORQ, a threaded implant designed for osteointegration; iFUSE BEDROCK GRANITE, which provides fusion and fixation for segmental spinal fusion; and iFUSE TORQ TNT, a porous threaded implant capable of spanning the posterior pelvis. These products are used in orthopedic procedures to address compromised bone conditions.